why choose us

First received: September 05, 2023

Clinical Trial: A Phase 1 Study of NM6603 in Advanced Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancers

Study Type: INTERVENTIONAL


Official Title: A Phase I Study to Determine the Maximum Tolerated Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of NM6603 in Patients With Advanced Solid Tumors

Brief Summary: This study is to assess the MTD and RP2D of NM6603 in adult patients with advanced solid tumors.

Read more